Danaher Co. (NYSE:DHR) Shares Sold by Benchmark Financial Wealth Advisors LLC

Benchmark Financial Wealth Advisors LLC trimmed its holdings in shares of Danaher Co. (NYSE:DHR) by 6.7% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 772 shares of the conglomerate’s stock after selling 55 shares during the period. Benchmark Financial Wealth Advisors LLC’s holdings in Danaher were worth $214,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Fort Pitt Capital Group LLC raised its holdings in shares of Danaher by 3.2% during the third quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock worth $66,194,000 after purchasing an additional 7,421 shares during the period. Good Life Advisors LLC acquired a new stake in shares of Danaher during the third quarter worth $217,000. Oak Thistle LLC acquired a new stake in shares of Danaher during the second quarter worth $363,000. Duality Advisers LP acquired a new stake in shares of Danaher during the first quarter worth $5,573,000. Finally, Diversified Trust Co raised its holdings in shares of Danaher by 75.4% during the second quarter. Diversified Trust Co now owns 4,360 shares of the conglomerate’s stock worth $1,090,000 after purchasing an additional 1,874 shares during the period. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Stock Performance

NYSE:DHR opened at $250.16 on Wednesday. Danaher Co. has a twelve month low of $192.35 and a twelve month high of $281.70. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The company has a 50-day moving average of $266.16 and a 200-day moving average of $260.84. The firm has a market cap of $180.68 billion, a price-to-earnings ratio of 47.74, a price-to-earnings-growth ratio of 4.55 and a beta of 0.85.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The company had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.59 billion. During the same quarter last year, the firm posted $2.02 EPS. The business’s revenue for the quarter was up 3.1% on a year-over-year basis. Analysts forecast that Danaher Co. will post 7.51 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were issued a $0.27 dividend. This represents a $1.08 annualized dividend and a dividend yield of 0.43%. The ex-dividend date of this dividend was Friday, September 27th. Danaher’s payout ratio is 20.61%.

Analyst Ratings Changes

A number of brokerages have weighed in on DHR. Stephens reissued an “overweight” rating and set a $315.00 target price on shares of Danaher in a report on Wednesday, October 23rd. Royal Bank of Canada dropped their price objective on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating on the stock in a report on Wednesday, October 23rd. Barclays dropped their price objective on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 23rd. Robert W. Baird dropped their price objective on shares of Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a report on Wednesday, October 23rd. Finally, TD Cowen increased their price objective on shares of Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Six equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $287.16.

Insiders Place Their Bets

In other Danaher news, SVP Georgeann Couchara sold 952 shares of the firm’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $268.37, for a total value of $255,488.24. Following the completion of the transaction, the senior vice president now directly owns 4,212 shares in the company, valued at $1,130,374.44. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 10.90% of the company’s stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.